We have located links that may give you full text access.
Comparative Study
English Abstract
Journal Article
[Lipoprotein(a): its concentrations in children with insulin-dependent diabetes mellitus].
Medicina Clínica 1995 April 23
BACKGROUND: Insulin-dependent diabetes mellitus (IDDM) is characterized by an increased risk of having cardiovascular diseases which have been associated to, among other factors, an increase in lipoprotein (a) [Lp(a)] levels.
METHODS: With the aim of analyzing the relationship between Lp(a) plasma levels and the degree of metabolic control in infantile diabetes mellitus their levels have been evaluated in children with IDDM and correlated with the degree of metabolic control and the length of disease evolution. The study was performed in a sample of 41 children diagnosed with IDDM and ages ranging from 2 to 9 years, and 82 normolipemic healthy children corresponding to the same ages and an equal proportion by sex. Cholesterol and total triglycerides, HDL, LDL and VLDL cholesterol, apolipoproteins AI and B were determined in all. Fasting glycemia, glycohemoglobin, serum fructosamine and creatinine clearance were used as markers of metabolic disease control.
RESULTS: No significant differences were observed in the Lp(a) values among sexes or age in the control group. Upon comparison of the Lp(a) values of the diabetic patients with the control group, no significant differences were observed. In the diabetic children, no differences were found between the Lp(a) values according to the glycohemoglobin values (X +/- SD g/l) (< 8% 0.16 +/- 0.13); (> or = 8% 0.21 +/- 0.26). The Lp(a) values were only increased in diabetic children with more than 5 years of evolution (control: 0.12 +/- 0.14, IDDM < or = 5 years; 0.16 +/- 0.16 and IDDM > 5 years: 0.34 +/- 0.31 [p < 0.01]).
CONCLUSIONS: The plasma levels of Lp(a) in diabetic children are significantly related to the length of disease evolution and are independent of the degree of metabolic control.
METHODS: With the aim of analyzing the relationship between Lp(a) plasma levels and the degree of metabolic control in infantile diabetes mellitus their levels have been evaluated in children with IDDM and correlated with the degree of metabolic control and the length of disease evolution. The study was performed in a sample of 41 children diagnosed with IDDM and ages ranging from 2 to 9 years, and 82 normolipemic healthy children corresponding to the same ages and an equal proportion by sex. Cholesterol and total triglycerides, HDL, LDL and VLDL cholesterol, apolipoproteins AI and B were determined in all. Fasting glycemia, glycohemoglobin, serum fructosamine and creatinine clearance were used as markers of metabolic disease control.
RESULTS: No significant differences were observed in the Lp(a) values among sexes or age in the control group. Upon comparison of the Lp(a) values of the diabetic patients with the control group, no significant differences were observed. In the diabetic children, no differences were found between the Lp(a) values according to the glycohemoglobin values (X +/- SD g/l) (< 8% 0.16 +/- 0.13); (> or = 8% 0.21 +/- 0.26). The Lp(a) values were only increased in diabetic children with more than 5 years of evolution (control: 0.12 +/- 0.14, IDDM < or = 5 years; 0.16 +/- 0.16 and IDDM > 5 years: 0.34 +/- 0.31 [p < 0.01]).
CONCLUSIONS: The plasma levels of Lp(a) in diabetic children are significantly related to the length of disease evolution and are independent of the degree of metabolic control.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app